Literature DB >> 6494610

Pulmonary involvement in Sjögren's syndrome.

F Bariffi, A Pesci, G Bertorelli, P Manganelli, U Ambanelli.   

Abstract

In this study we tried to value the frequency and the characteristics of the physiological abnormalities affecting the lungs in Sjögren's syndrome (SS). We studied 18 female nonsmokers (average age 53 years). The diagnosis has been made on the presence of at least two of the following abnormalities: keratoconjunctivitis sicca (Schirmer's test), xerostomia (scanning of the salivary glands, lip biopsy) and collagen vascular disease. We made the following tests: clinical examination, chest roentgenogram, spirometry, TGV, RAW and SAW valuation, study of the flow-volume curves, diffusion capacity test, bronchoalveolar lavage, bronchial biopsy. The physiological results have demonstrated the presence of a restrictive syndrome affecting above all the small airways (MEF25-32.7%) and a decrease of the diffusion capacity (DLCO-25%). There is, moreover, a constant lymphocytic infiltration of the bronchial mucosa and of the lung's interstitium. In conclusion the pulmonary involvement in SS seems to be constant, unpredictable and of remarkable clinical-physiological importance.

Entities:  

Mesh:

Year:  1984        PMID: 6494610     DOI: 10.1159/000194674

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

Review 1.  Subclinical alveolitis in immunologic systemic disorders.

Authors:  B Wallaert
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  A follow-up study of pulmonary function in patients with primary Sjögren's syndrome.

Authors:  M Linstow; N J Kriegbaum; V Backer; C Ulrik; P Oxholm
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease.

Authors:  Aryeh Fischer; Jeffrey J Swigris; Roland M du Bois; Steve D Groshong; Carlyne D Cool; Hakan Sahin; David A Lynch; JoAnn Z Gillis; Marc D Cohen; Richard T Meehan; Kevin K Brown
Journal:  Chest       Date:  2009-05-08       Impact factor: 9.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.